Hepatic toxicity and clopidogrel-induced systemic inflammatory response syndrome [1];Toxicidad hepática y síndrome de respuesta inflamatoria sistémica por clopidogrel

Revista Espanola de Cardiologia

Volumn 60, Issue 3, 2007, Pages 323-324

  López Vicente, Jorge ^a   Garfia, Cristina ^a   López Medrano, Francisco ^a   Yela, Carmen ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BROMAZEPAM; CARVEDILOL; CLOPIDOGREL; LISINOPRIL; PIPERACILLIN PLUS TAZOBACTAM; TICLOPIDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; APLASTIC ANEMIA; ARTERIAL PRESSURE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; CASE REPORT; CLOSTRIDIUM DIFFICILE; CORONARY STENT; ECHOGRAPHY; GASTROINTESTINAL SYMPTOM; HUMAN; LABORATORY TEST; LETTER; LIVER TOXICITY; MALE; PRURITUS; RASH; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTOPENIC PURPURA; THROMBOSIS;

EID: 34247899143     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(07)75037-6     Document Type: Letter

References (6)

1. Jarvis B, Simpson K. Clopidogrel: a review of its use in the prevention of a atherothrombosis. Drugs. 2000;60:347-77.
2. Wolf I, Mouallem M, Rath S, Farfel Z. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc. 2003; 78:618-20.
3. Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349: 474-85.
4. María VAJ, Victorino RMM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997;26:664-9.
5. Beltrán-Robles M, Márquez Saavedra E, Sánchez Muñoz D, Romero Gómez M. Hepatoxicity induced by clopidogrel. J Hepatol. 2004;40:560-2.
6. Clarke TA, Waskell LA. Clopidogrel is metabolized by human cytochrome P4503A and inhibited by atorvastatin. Drug Metab Dispos. 2003;31:53-9.